IRIS
TESSITORE, SARA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 631
AS - Asia 7
SA - Sud America 3
Totale 641
Salva come PNG Salva come JPEG
Nazione #
IT - Italia 631
CN - Cina 6
BR - Brasile 2
AR - Argentina 1
SG - Singapore 1
Totale 641
Salva come PNG Salva come JPEG
Città #
Genoa 523
Vado Ligure 106
Beijing 6
Aparecida de Goiânia 1
Bordighera 1
Don Torcuato 1
Milan 1
Olímpia 1
Singapore 1
Totale 641
Salva come PNG Salva come JPEG
Nome #
The complex phenotype and function of spinal cord microglia during ALS progression and the impact of metabotropic glutamate receptor type 5 down-regulation in SOD1G93A mice 86
Genetic Downregulation of the Metabotropic Glutamate Receptor Type 5 Dampens the Reactive and Neurotoxic Phenotype of Adult ALS Astrocytes 82
mGlu5 receptor negative allosteric modulation reduces the aberrant cellular reactivity and neurotoxicity of reactive human astrocytes differentiated from fibroblast of SOD1 and C9orf72 ALS patients 78
Genetic and pharmacological effects by blocking mGlu5 receptor in the SOD1G93A mouse model of amyotrophic lateral sclerosis 68
Preclinical study showing a gender specific protective properties of conjugated linoleic acid (CLA) for amyotrophic lateral sclerosis 65
Reactive Astrocytes from patients affected by Amyotrophic Lateral Sclerosis: how mGlu5 receptor modulation affects pathological features 51
mGlu5 receptor negative allosteric modulation reduces the aberrant cellular reactivity and neurotoxicity of iNPCs-derived human astrocytes differentiated from ALS patients 44
The mGlu5 receptor negative allosteric modulator CTEP as a pharmacological tool to dampen ALS disease progression: in-vivo preclinical studies and clinical perspectives 38
The negative allosteric modulator CTEP ameliorates the reactive phenotype of iastrocytes from patients affected by Amyotrophic Lateral Sclerosis 32
Preventive effects of conjugated linoleic acid (CLA) in-vivo oral treatment in the SOD1G93A preclinical model of amyotrophic lateral sclerosis 30
Reactive phenotype and oxidative stress in i-Astrocytes from patients affected by Amyotrophic Lateral Sclerosis: how the mGluR5 negative allosteric modulator CTEP affects these pathological features 29
The negative allosteric modulator CTEP ameliorates the reactive phenotype of iastrocytes from patients affected by Amyotrophic Lateral Sclerosis 29
The negative allosteric modulator CTEP ameliorates the reactive phenotype of human-derived iAstrocytes differentiated from iNPCs of patients affected by Amyotrophic Lateral Sclerosis 28
Totale 660
Salva come PNG Salva come JPEG
Categoria #
all - tutte 2.257
article - articoli 452
book - libri 0
conference - conferenze 1.694
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 4.403
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2023/202468 0 5 1 3 1 3 1 1 0 9 19 25
2024/2025320 17 13 3 20 33 31 30 57 20 24 40 32
2025/2026272 72 37 100 63 0 0 0 0 0 0 0 0
Totale 660